Adalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet’s disease and secondary myelodysplastic syndrome

Adalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet’s disease and secondary myelodysplastic syndromeAdalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet’s disease and secondary myelodysplastic syndrome, Published online: 27 April 2018; doi:10.1038/s41409-018-0180-yAdalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet’s disease and secondary myelodysplastic syndrome

Source: Bone Marrow Transplantation - April 27, 2018 Category: Hematology Authors: Maiko Noguchi Hiroshi Moritake Sachiyo Kamimura Motoshi Sonoda Masataka Ishimura Jiro Inagaki Source Type: research